• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原位抗原捕获纳米伴侣体用于癌症免疫治疗的个体化纳米疫苗

In Situ Antigen-Capturing Nanochaperone Toward Personalized Nanovaccine for Cancer Immunotherapy.

机构信息

Key Laboratory of Functional Polymer Materials of Ministry of Education, State Key Laboratory of Medicinal Chemical Biology, Institute of Polymer Chemistry and College of Chemistry, Nankai University, Tianjin, 300071, P. R. China.

State Key Laboratory of Separation Membranes and Membrane Processes and School of Materials Science and Engineering, Tiangong University, Tianjin, 300387, P. R. China.

出版信息

Small. 2022 Aug;18(32):e2203100. doi: 10.1002/smll.202203100. Epub 2022 Jul 17.

DOI:10.1002/smll.202203100
PMID:35843873
Abstract

Personalized cancer vaccination using nanomaterials holds great potential for cancer immunotherapy. Here, a nanochaperone (PBA-nChap) is tailored for in situ capture of tumor-associated antigens (TAAs) to improve cancer immunotherapy. The PBA-nChap is capable of i) efficiently capturing TAAs in situ; ii) protecting TAAs from degradation; iii) transporting TAAs to antigen-presenting cells and promoting cross-presentation. Intratumor injection of PBA-nChap in combination with pretreatment with photodynamic therapy (PDT) significantly enhances immune response and exhibits excellent antitumor efficacy. Moreover, nanovaccine prepared by simply co-culturing PBA-nChap with tumor cell fragments from surgery resected primary tumor in vitro synergized with immune checkpoint blockade (ICB) therapy can effectively inhibit tumor recurrence and metastasis after an operation. This work provides a promising platform for personalized cancer vaccination.

摘要

利用纳米材料进行个体化癌症疫苗接种在癌症免疫治疗方面具有巨大潜力。在这里,一种纳米伴侣(PBA-nChap)被设计用于原位捕获肿瘤相关抗原(TAAs),以提高癌症免疫治疗效果。PBA-nChap 能够:i)高效原位捕获 TAA;ii)保护 TAA 免受降解;iii)将 TAA 转运至抗原呈递细胞并促进交叉呈递。肿瘤内注射 PBA-nChap 联合光动力治疗(PDT)预处理可显著增强免疫反应,并表现出优异的抗肿瘤疗效。此外,通过简单地将 PBA-nChap 与手术切除的原发性肿瘤细胞碎片在体外共培养制备的纳米疫苗与免疫检查点阻断(ICB)治疗协同作用,可有效抑制手术后的肿瘤复发和转移。这项工作为个体化癌症疫苗接种提供了一个有前途的平台。

相似文献

1
In Situ Antigen-Capturing Nanochaperone Toward Personalized Nanovaccine for Cancer Immunotherapy.原位抗原捕获纳米伴侣体用于癌症免疫治疗的个体化纳米疫苗
Small. 2022 Aug;18(32):e2203100. doi: 10.1002/smll.202203100. Epub 2022 Jul 17.
2
Controlled Refolding of Denatured IL-12 Using In Situ Antigen-Capturing Nanochaperone Remarkably Reduces the Systemic Toxicity and Enhances Cancer Immunotherapy.原位抗原捕获纳米分子伴侣控制变性 IL-12 的复性,显著降低了系统性毒性并增强了癌症免疫治疗。
Adv Mater. 2024 May;36(19):e2309927. doi: 10.1002/adma.202309927. Epub 2024 Mar 3.
3
Mimetic Heat Shock Protein Mediated Immune Process to Enhance Cancer Immunotherapy.模拟热休克蛋白介导的免疫过程以增强癌症免疫治疗。
Nano Lett. 2020 Jun 10;20(6):4454-4463. doi: 10.1021/acs.nanolett.0c01230. Epub 2020 May 19.
4
A generally minimalist strategy of constructing biomineralized high-efficiency personalized nanovaccine combined with immune checkpoint blockade for cancer immunotherapy.一种构建仿生高效个体化纳米疫苗的极简策略,结合免疫检查点阻断用于癌症免疫治疗。
Biomaterials. 2022 Oct;289:121794. doi: 10.1016/j.biomaterials.2022.121794. Epub 2022 Sep 7.
5
A Nanovaccine Based on Adjuvant Peptide FK-13 and l-Phenylalanine Poly(ester amide) Enhances CD8 T Cell-Mediated Antitumor Immunity.基于佐剂肽 FK-13 和 l-苯丙氨酸聚酯酰胺的纳米疫苗增强了 CD8 T 细胞介导的抗肿瘤免疫。
Adv Sci (Weinh). 2023 Jul;10(20):e2300418. doi: 10.1002/advs.202300418. Epub 2023 May 10.
6
Self-assembly nanovaccine containing TLR7/8 agonist and STAT3 inhibitor enhances tumor immunotherapy by augmenting tumor-specific immune response.自组装纳米疫苗包含 TLR7/8 激动剂和 STAT3 抑制剂,通过增强肿瘤特异性免疫反应增强肿瘤免疫治疗。
J Immunother Cancer. 2021 Aug;9(8). doi: 10.1136/jitc-2021-003132.
7
Combination of Sunitinib and PD-L1 Blockade Enhances Anticancer Efficacy of TLR7/8 Agonist-Based Nanovaccine.舒尼替尼与 PD-L1 阻断联合增强 TLR7/8 激动剂纳米疫苗的抗癌疗效。
Mol Pharm. 2019 Mar 4;16(3):1200-1210. doi: 10.1021/acs.molpharmaceut.8b01165. Epub 2019 Jan 25.
8
In Situ Cocktail Nanovaccine for Cancer Immunotherapy.原位鸡尾酒纳米疫苗用于癌症免疫治疗。
Adv Sci (Weinh). 2023 Nov;10(31):e2207697. doi: 10.1002/advs.202207697. Epub 2023 Sep 22.
9
An MRI-trackable therapeutic nanovaccine preventing cancer liver metastasis.一种可磁共振追踪的治疗性纳米疫苗,可预防癌症肝转移。
Biomaterials. 2021 Jul;274:120893. doi: 10.1016/j.biomaterials.2021.120893. Epub 2021 May 19.
10
Nanoscale Metal-Organic Frameworks for Cancer Immunotherapy.用于癌症免疫治疗的纳米级金属有机框架
Acc Chem Res. 2020 Sep 15;53(9):1739-1748. doi: 10.1021/acs.accounts.0c00313. Epub 2020 Aug 18.

引用本文的文献

1
Nanovaccines empowering CD8 T cells: a precision strategy to enhance cancer immunotherapy.纳米疫苗增强CD8 T细胞:一种增强癌症免疫疗法的精准策略。
Theranostics. 2025 Feb 10;15(7):3098-3121. doi: 10.7150/thno.107856. eCollection 2025.
2
Personalized nanovaccines for treating solid cancer metastases.用于治疗实体癌转移的个体化纳米疫苗。
J Hematol Oncol. 2024 Nov 28;17(1):115. doi: 10.1186/s13045-024-01628-4.
3
Mn(iii)-mediated carbon-centered radicals generate an enhanced immunotherapeutic effect.三价锰介导的碳中心自由基产生增强的免疫治疗效果。
Chem Sci. 2023 Dec 6;15(2):765-777. doi: 10.1039/d3sc03635a. eCollection 2024 Jan 3.
4
Recent Advances in Cancer Immunotherapy Delivery Modalities.癌症免疫治疗递送方式的最新进展
Pharmaceutics. 2023 Feb 2;15(2):504. doi: 10.3390/pharmaceutics15020504.